T
Takeda Pharmaceutical
TAK
Reported
Thursday, October 31
Q2 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | 0.57 | 0.45 | -0.12 | -21.05% |
| Revenue | - | 7.90B | - | - |
WhatIF - Earnings
EPS Missed Expectations by -$0.12
Takeda Pharmaceutical (TAK:NYSE) has never missed EPS by this much before
There’s a first time for everything